# Kelly K. Hunt

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kelly-k-hunt/

## Facts

| Field | Value |
| --- | --- |
| Citations | 61,868 |
| Field | Breast Cancer Treatment Studies |
| h-index | 131 |
| i10-index | 614 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5017411324 |
| ORCID iD | https://orcid.org/0000-0001-9156-8723 |
| Works | 1,418 |

## Researcher papers

Showing 12 of 14.

- [Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy](https://scholariq.org/papers/clinical-course-of-breast-cancer-patients-with-complete-pathologic-primary-tumor/)
- [Whole-genome analysis informs breast cancer response to aromatase inhibition](https://scholariq.org/papers/whole-genome-analysis-informs-breast-cancer-response-to-aromatase-inhibition/)
- [Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011](https://scholariq.org/papers/surgical-complications-associated-with-sentinel-lymph-node-dissection-slnd-plus/)
- [Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection](https://scholariq.org/papers/improved-axillary-evaluation-following-neoadjuvant-therapy-for-patients-with/)
- [Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial](https://scholariq.org/papers/surgical-complications-associated-with-sentinel-lymph-node-biopsy-results-from-a/)
- [Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031](https://scholariq.org/papers/randomized-phase-ii-neoadjuvant-comparison-between-letrozole-anastrozole-and/)
- [Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0–T4, N1–N2) Who Receive Neoadjuvant Chemotherapy](https://scholariq.org/papers/identification-and-resection-of-clipped-node-decreases-the-false-negative-rate/)
- [Tumor Biology Correlates With Rates of Breast-Conserving Surgery and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer](https://scholariq.org/papers/tumor-biology-correlates-with-rates-of-breast-conserving-surgery-and-pathologic/)
- [Breast Conservation After Neoadjuvant Chemotherapy: The M.D. Anderson Cancer Center Experience](https://scholariq.org/papers/breast-conservation-after-neoadjuvant-chemotherapy-the-m-d-anderson-cancer/)
- [Long-Term Results of Two Prospective Trials of Preoperative External Beam Radiotherapy for Localized Intermediate- or High-Grade Retroperitoneal Soft Tissue Sarcoma](https://scholariq.org/papers/long-term-results-of-two-prospective-trials-of-preoperative-external-beam/)
- [Validation Study of the American Joint Committee on Cancer Eighth Edition Prognostic Stage Compared With the Anatomic Stage in Breast Cancer](https://scholariq.org/papers/validation-study-of-the-american-joint-committee-on-cancer-eighth-edition/)
- [Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery](https://scholariq.org/papers/identification-of-patients-with-documented-pathologic-complete-response-in-the/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)
- [Breast Implant and Reconstruction](https://scholariq.org/topics/breast-implant-and-reconstruction/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer-related Molecular Pathways](https://scholariq.org/topics/cancer-related-molecular-pathways/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.